How to Build a Longevity Benefits Business Case Your CFO Will Approve

You already believe a longevity benefit could help your people. The hard part is getting the budget. Leadership rarely says no because an idea is bad; most proposals stall because nobody framed them in the terms decision-makers actually use. A strong longevity benefits business case closes that gap.

The central shift is simple to describe and harder to practice: stop selling health and start speaking business. Your CFO and CEO decide in the language of cost, risk, talent and strategy. The program does not change. The language does.

This guide walks through the four arguments that carry a longevity proposal, how to use numbers without overpromising, how to answer the objections you will hear, and how to fit the whole thing on one page. It draws on the business case and champion playbook material in the Certified Corporate Longevity Specialist™ (CCLS) program.

The four arguments behind a longevity benefits business case

Almost every successful proposal rests on some mix of four arguments. You do not need to lead with all of them, but you should be ready to make each one clearly and honestly.

1. Protect the cost. In most employer health plans, a small share of people drive most of the spend, usually through advanced conditions such as late-stage cancer or a major cardiac event. Those conditions tend to have long silent windows before symptoms appear. A longevity program is built to find risk inside that window, when it is far cheaper to address. A cancer caught at stage one costs a fraction of one caught at stage four, in dollars and in human terms.
2. Win and keep talent. Most benefits are commodities. A serious longevity benefit is rare, personal and valuable, which makes it a genuine retention tool, especially for leaders and key roles who are expensive to replace.
3. Protect performance. Healthier people are present and sharp rather than distracted by undiagnosed problems or out on extended leave. For senior leaders, a sudden health crisis can stall decisions across the business, so protecting their health protects continuity.
4. Lead, don't follow. Corporate health is moving from reactive sick care toward proactive, data-driven care. Acting early positions the company as an employer of the future rather than a late adopter.

The cost argument deserves particular care. Savings depend on the population and the program design, so present the mechanism, not a promised figure. If you need a refresher on how early detection works in practice, our explainer on longevity biomarkers covers the markers that make it possible.

Match the argument to the decision-maker

The same four arguments land differently depending on who is across the table. Read the room and reorder your case accordingly, keeping the other arguments in reserve.

• The CFO: lead with cost protection. Talk about risk, claims, and the concentration of spend in expensive, catchable cases.
• The CEO: lead with talent, performance and strategy. Talk about retaining key leaders, protecting the continuity of the leadership team, and being early on a real shift.
• The HR or benefits leader: lead with talent, equity, and a program they would be proud to run.

The executive population is often the natural starting point. Roughly half of senior executives are already paying for longevity care personally, out of pocket and after tax, which means you are often proposing to organize and improve something that is already happening. Our primer on the executive longevity benefit explains why that group makes such a practical wedge.

How to use numbers honestly (and why the pilot wins)

It is tempting to promise that a program will save a set amount for every dollar spent. Resist it. Specific ROI promises in this space are usually unprovable, and a sharp finance leader will see through them. Once they catch one inflated number, they stop trusting the parts of your case that were true.

Instead, use three honest moves:

• Start with the company's own data. Actual claims and cost patterns are specific and far more persuasive than industry averages.
• Show the logic, not a promise. Explain how early detection lowers cost rather than promising a precise dollar figure.
• Propose a pilot, then measure. Offer a focused pilot that generates the company's own real numbers to decide on.

The pilot is the single most useful move in the whole conversation. When a discussion bogs down in projections, you can say: let's not argue about projections, let's run a pilot and get your real numbers. That lowers the upfront ask, sidesteps the unprovable ROI debate, and turns the decision into a low-risk experiment. A pilot only works as proof if you capture a baseline before it starts, which is why the measurement plan belongs in the proposal from day one. Our guide to measuring a corporate longevity program covers what to track.

Answering the four objections you will hear

Pushback is normal. The difference between an amateur and a professional is having calm, prepared answers ready before the meeting.

• "It's too expensive." Tier it and pilot it. Start small, prove value, and expand on results, matching cost to value at each level.
• "The ROI is unproven." Agree honestly, then turn the objection into the pilot that produces the company's own evidence.
• "Isn't this just a perk for executives?" Show the foundation tier that reaches everyone. A tiered design is the equity answer, as outlined in our guide to designing a longevity benefit.
• "We already have wellness." Explain the difference. Traditional wellness struggled to prove it worked. The Illinois Workplace Wellness Study, a randomized trial by University of Chicago and University of Illinois researchers published in the Quarterly Journal of Economics and JAMA Internal Medicine, found no significant effect on health, spending or productivity. A longevity program measures the body, re-measures it, and can show what changed.

Your posture matters as much as your answers. Show up as a trusted advisor, not a salesperson. Name the real costs and risks openly. The person who acknowledges the downsides is the one leadership believes about the upsides.

The one-page longevity business case

If you cannot say it on a page, you cannot say it in a meeting. Build a detailed version for the questions, but lead with a single page structured in four parts:

1. The problem. Health costs and talent risk in this company's own terms, and why now.
2. The proposal. The tiered program in brief: what it is and who it reaches.
3. The ask. A specific, low-risk pilot with a clear scope, cost and timeline. The smaller and clearer the ask, the easier the yes.
4. The proof plan. How you will measure results and decide on expansion. Honest, not hyped.

Brevity here signals mastery. A busy executive can absorb this in two minutes, and clarity is what gets a decision.

From approval to a program that lasts

A case is an argument, but approval usually comes from a campaign. Decisions happen through people over weeks or months. Win a respected senior sponsor first, since one credible leader saying "I'm behind this" outweighs a stack of slides. Then bring in early believers and the quiet influencers others listen to, and connect the program to what each of them already cares about.

Once you get the yes, protect the first win. Launch with the most willing group, capture results from day one, and share progress in a privacy-safe, aggregate way. The first program becomes the proof for every budget conversation that follows.

Key takeaways

• Translate health into business: speak cost, risk, talent and strategy, not biomarkers.
• Build on four arguments (protect cost, keep talent, protect performance, lead the shift) and lead with the one your audience cares about most.
• Never promise a precise ROI. Use the company's own data and let a pilot generate real proof.
• Fit the case on one page: problem, proposal, ask, proof plan.
• Approval is the start. Protect the first win and measure it from day one.

Making the case and championing it through an organization are skills you can learn. The CCLS™ program, created by Jonathan Edelheit and issued by the Corporate Health & Wellness Association in partnership with Healthcare Revolution, covers both in its Strategy tier. Explore the 13 modules or enroll today to start building a proposal leadership can approve.

About this article. Written by the CCLS editorial team, drawing on the curriculum of the Certified Corporate Longevity Specialist™ program, issued by the Corporate Health & Wellness Association in partnership with Healthcare Revolution. Learn who created the program.